WebDisclosure WebDisclosure
Basculer en Français
9904 Companies
199533 Keywords
130386 Articles
106040 Press releases
Headlines Articles Press releases Propelus Remove
  1. Home
  2. Companies
  3. Propelus
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/30/2024 at 17:50, 1 year 9 months ago

    CE Broker de Propelus s'associe au Texas Medical Board pour améliorer la formation continue

    Conformité Des Soins De Santé Formation Continue Licence Professionnelle Courtier CE Conseil Médical Du Texas
  • PRESS RELEASE

    published on 04/30/2024 at 17:45, 1 year 9 months ago

    CE Broker by Propelus and Texas Medical Board Forge Alliance to Modernize Continuing Education

    CE Broker by Propelus announces strategic partnership with the Texas Medical Board to modernize continuing education management for licensed professionals. The collaboration aims to revolutionize the education process
    Partnership Continuing Education CE Broker Texas Medical Board Propelus
    Logo of Propelus
  • PRESS RELEASE

    published on 08/01/2023 at 14:00, 2 years 6 months ago

    Introducing Propelus: Healthcare Compliance Leader Unveils New Company Brand to Focus on Powering Professionals

    Logo of Propelus
Previous page
1 2
Accesswire
  • Published on 02/20/2026 at 18:30, 14 minutes ago

    Sparta Updates Delay in Filing Annual Financial Statements

  • Published on 02/20/2026 at 15:45, 2 hours 59 minutes ago

    Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway

  • Published on 02/20/2026 at 14:30, 4 hours 14 minutes ago

    Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

  • Published on 02/20/2026 at 14:08, 4 hours 36 minutes ago

    Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange

  • Published on 02/20/2026 at 14:00, 4 hours 44 minutes ago

    Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE
EQS Group
  • Published on 02/20/2026 at 18:36, 7 minutes ago

    EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share

  • Published on 02/20/2026 at 18:31, 12 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 02/20/2026 at 18:23, 20 minutes ago

    POS-Transaction in Own Shares

  • Published on 02/20/2026 at 18:00, 43 minutes ago

    Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme

  • Published on 02/20/2026 at 18:00, 43 minutes ago

    Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS
Les Echos
  • Published on 02/20/2026 at 18:00, 44 minutes ago

    TERACT - Termination of liquidity agreement

  • Published on 02/20/2026 at 18:00, 44 minutes ago

    TERACT - Résiliation du contrat de liquidité

  • Published on 02/20/2026 at 17:35, 1 hour 9 minutes ago

    CHIFFRE D'AFFAIRES 2025

  • Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago

    Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026

  • Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy